Two new cancer care initiatives -- Medicare's  Enhancing Oncology Model and the Patient-Centered Cancer Care Certification from the American Society of Clinical Oncology, or ASCO -- aim to improve patient outcomes and fight rising costs.

Both initiatives have lofty goals, but can they attain them? And how will they impact manufacturers and market access?

Today's guest is John Hennessy, Senior Vice President, Strategist with Valuate Health Consultancy. 

The IDI is presented by Valuate Health Consultancy. 

Follow Valuate on LinkedIn to learn more.